BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 29, 2006
View Archived Issues
Targeting IGF-1R shows antitumor efficacy in mouse models of lung cancer
Read More
Ruboxistaurin reduces the risk of vision loss in diabetic retinopathy
Read More
Licorice component protects mice against DMN-induced lung and colon tumors
Read More
Efficacy of targeting the adenosine A3 receptor shown in patients with rheumatoid arthritis
Read More
Targets in nephrology
Read More
Novel preclinical data on Zyflamend's antitumor mechanism
Read More
Davanat studied in phase II first-line colorectal cancer study
Read More
GV-1001 begins phase II trial in liver cancer
Read More
FDA accepts complete response for Factive in five-day treatment of CAP
Read More
QSC-001 begins clinical program
Read More
Kamada begins phase I trials with inhaled API product for congenital emphysema
Read More
Neose receives milestone payment under Factor VIIa agreement with Novo Nordisk
Read More
Biota and Boehringer Ingelheim enter HCV licensing agreement
Read More
First generic ondansetron injection products approved in U.S.
Read More
Lundbeck and Biotie sign agreement for nalmefene
Read More
Novartis presents pipeline review
Read More
No reported increase in Tamiflu resistance
Read More
Cytokinetics and GSK amend license and collaboration agreement
Read More
Biocon working towards launch of antiarthritis drug in India
Read More
New pivotal study begins for Clolar in adult AML
Read More
Enrollment complete in phase II trial of MitoQ in Parkinson's disease
Read More
Sankyo patents novel compounds for transplant rejection, autoimmune diseases, etc.
Read More
Novel Rho kinase inhibitors revealed in D. Western Therapeutics patents
Read More
TRK-820 filed in Japan for severe uremic pruritus in hemodialysis patients
Read More
Recent patents disclose novel agents with potential in the treatment of HCV infection
Read More